Impact of Collagen Triple Helix Structure on Melanoma Cell Invadopodia Formation and Matrix Degradation upon BRAF Inhibitor Treatment
- 25 November 2021
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (7) , 2101592-e2101592
Abstract
A collagen‐rich tumor microenvironment (TME) is associated with worse outcomes in cancer patients and contributes to drug resistance in many cancer types. In melanoma, stiff and fibrillar collagen‐abundant tissue is observed after failure of therapeutic treatments with BRAF inhibitors. Increased collagen in the TME can affect properties of the extracellular matrix (ECM), including stiffness, adhesiveness, and interaction of integrins with triple helix forming nanostructures. Decoupling these biochemical and biophysical properties of the ECM can lead to a better understanding of how each of these individual properties affect melanoma cancer behavior and drug efficacy. In addition, as drug treatment can induce cancer cell phenotypic switch, cancer cell responsiveness to the TME can be dynamically changed during therapeutic treatments. To investigate cancer cell phenotype changes and the role of the cancer TME, poly(ethylene glycol) (PEG) hydrogels functionalized with collagen mimetic peptides (CMPs) is utilized, or an interpenetrating network (IPN) of type І collagen within the PEG system to culture various melanoma cell lines in the presence or absence of Vemurafenib (PLX4032) drug treatment is prepared. Additionally, the potential of using CMP functionalized PEG hydrogels, which can provide better tunability is explored, to replace the existing invadopodia assay platform based on fluorescent gelatin.Keywords
Funding Information
- National Institutes of Health (R01 DE016523, RO1 HL132353, T32 HL007822)
This publication has 38 references indexed in Scilit:
- Collagen and collagen mimetic peptide conjugates in polymer scienceEuropean Polymer Journal, 2013
- Targeting collagen strands by photo-triggered triple-helix hybridizationProceedings of the National Academy of Sciences, 2012
- Aligned Collagen Is a Prognostic Signature for Survival in Human Breast CarcinomaThe American Journal of Pathology, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Size-Dependent Rheology of Type-I Collagen NetworksBiophysical Journal, 2010
- PEG-Based Hydrogels with Collagen Mimetic Peptide-Mediated and Tunable Physical Cross-LinksBiomacromolecules, 2010
- Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibilityBiomaterials, 2009
- Extracellular Matrix Rigidity Promotes Invadopodia ActivityCurrent Biology, 2008
- Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanomaInternational Journal of Cancer, 2007
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006